Prognostic factors of young patients with colon cancer after surgery

Table 1 Prognostic factors of young patients with colon cancer after surgery

Items		Number of cases	AST(m)	3-YSR (%)	5-YSR (%)	10-YSR (%)	t	Degree of freedom	P value
Gender Age Duration of symptoms (m) Operation Radical resection Blood transfusion (mL) Pathological type Diameter of tumor (cm) T N M	Male Female ≤30 30-40 ≤1 1-3 3-6 6-12 ≥12 LHC RHC TCR LAR R0 R1 R2 0 400 ≥800 WDAC MDAC PDAC PAC MAC SRCC Others ≤4 4-8 ≥8 T1 T2 T3 T4 N0 N1 N2 M0 M1	58 38 30 66 15 37 25 5 14 43 37 9 7 69 4 23 60 29 7 5 27 18 4 27 3 12 16 53 27 4 10 58 24 45 30 21 75 21	81 ± 6.42 73.62 ± 7.92 49 ± 5.47 82.74 ± 5.76 34 ± 5.28 108 ± 30.25 69 71.80 ± 20.15 80.55 ± 12.34 67 ± 1.95 78 ± 9.00 52 ± 20.99 37 98.2 ± 4.92 32 ± 3.50 24 ± 2.04 85 ± 6.3 69 ± 8.7 31 ± 9.89 92.75 ± 15.80 101.89 ± 7.20 31 ± 3.09 58.75 ± 11.47 60 ± 24.73 23.33 ± 5.39 76 ± 15.11 101.19 ± 9.68 84.02 ± 6.25 31 ± 8.83 - 111.5 ± 8.06 108 ± 29.54 24 ± 3.13 111.71 ± 3.93 37 ± 2.42 23 ± 2.86 94.59 ± 4.95 24 ± 2.29	69.92 62.48 52.50 73.32 45 77.04 60 53.33 78.57 97.14 83.20 85.71 66.67 87.92 50 6.52 72.59 61.29 35.71 100 88.09 37.50 75 67.73 0 58.33 78.97 76.79 39.16 100 90 82.34 10.33 95 51.85 28.57 84.66 4.76	61.35 53.69 47.73 63.12 36 67.56 60 53.33 56.25 60.43 62.04 42.86 0 77.67 75 0 64.10 54.08 17.86 75 83.68 31.25 75 46.95 0 58.33 78.97 61.93 39.16 100 90 68.15 - 91.72 34.90 19.05 73.58 0	45.30 48.32 47.73 49.55 - 40.04 50 - 56.25 10.34 15.75 0 0 63.40 75 0 59.17 38.93 - - 75.32 - - 31.30 0 58.33 78.97 48.38 - 100 90 38.94 - 78.62 29.08 - 61.45 0	0.46 2.4 5.33 9.43 80.72 7.69 21.69 14.16 57.91 51.40 80.03	1 1 4 3 2 2 6 2 3 2 1	0.499 0.0387 0.2553 0.0241 <0.01 0.0214 0.0014 <0.001 <0.001 <0.001 <0.001

AST: average survival time; 3-YSR: 3-year survival rate; 5-YSR: 5-year survival rate; 10-YSR: 10-year survival rate; LHC: left hemicolectomy; RHC: right hemicolectomy; TCR: transverse colon resection; WDAC: well-differentiated adenocarcinoma; MDAC: moderately-differentiated adenocarcinoma; PDAC: poorly-differentiated adenocarcinoma; PAC: papillary adenocarcinoma; MAC: mucinous adenocarcinoma; SRCC: signet-ring cell carcinoma